Sakamoto S - Search Results

1

A case of bladder cancer after bilateral lung transplantation following bone marrow transplantation.

Arai Y, Goto Y, Sazuka T, Fujimoto A, Sato H, Imamura Y, Sakamoto S, Ota M, Ikeda JI, Ichikawa T. Arai Y, et al. Among authors: sakamoto s. IJU Case Rep. 2023 Oct 4;6(6):471-474. doi: 10.1002/iju5.12651. eCollection 2023 Nov. IJU Case Rep. 2023. PMID: 37928309 Free PMC article.

2

Loss of heterozygosity on chromosome 2 in Japanese patients with prostate cancer.

Ueda T, Komiya A, Suzuki H, Shimbo M, Sakamoto S, Imamoto T, Akakura K, Shiraishi T, Ichikawa T. Ueda T, et al. Among authors: sakamoto s. Prostate. 2005 Aug 1;64(3):265-71. doi: 10.1002/pros.20228. Prostate. 2005. PMID: 15717310

3

Interleukin-4 in patients with prostate cancer.

Takeshi U, Sadar MD, Suzuki H, Akakura K, Sakamoto S, Shimbo M, Suyama T, Imamoto T, Komiya A, Yukio N, Ichikawa T. Takeshi U, et al. Among authors: sakamoto s. Anticancer Res. 2005 Nov-Dec;25(6C):4595-8. Anticancer Res. 2005. PMID: 16334148 Free article.

4

Bisphosphonate and low-dose dexamethasone treatment for patients with hormone-refractory prostate cancer.

Ueda T, Suzuki H, Akakura K, Ishihara M, Kamiya N, Komiya A, Shimbo M, Suyama T, Sakamoto S, Ichikawa T. Ueda T, et al. Among authors: sakamoto s. Hinyokika Kiyo. 2006 Jul;52(7):515-21. Hinyokika Kiyo. 2006. PMID: 16910582 Free article.

5

Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.

Fuse M, Nohata N, Kojima S, Sakamoto S, Chiyomaru T, Kawakami K, Enokida H, Nakagawa M, Naya Y, Ichikawa T, Seki N. Fuse M, et al. Among authors: sakamoto s. Int J Oncol. 2011 Apr;38(4):1093-101. doi: 10.3892/ijo.2011.919. Epub 2011 Jan 21. Int J Oncol. 2011. PMID: 21258769

6

[Genetic diagnosis of prostate cancer: overview].

Sakamoto S, Ichikawa T. Sakamoto S, et al. Nihon Rinsho. 2011 Jun;69 Suppl 5:71-4. Nihon Rinsho. 2011. PMID: 22207945 Review. Japanese. No abstract available.

7

[Prostate cancer].

Sakamoto S, Ichikawa T. Sakamoto S, et al. Gan To Kagaku Ryoho. 2012 Jan;39(1):43-7. Gan To Kagaku Ryoho. 2012. PMID: 22454983 Review. Japanese. No abstract available.

8

Analysis of energy loss mediated by an alpha-1 blocker in patients with benign prostatic hyperplasia using a virtual urethra processed from an endoscopic video image.

Sazuka T, Kambara Y, Ishii T, Nakamura K, Sakamoto S, Naya Y, Yamanishi T, Ichikawa T, Igarashi T. Sazuka T, et al. Among authors: sakamoto s. J Endourol. 2012 Sep;26(9):1216-20. doi: 10.1089/end.2012.0078. Epub 2012 May 8. J Endourol. 2012. PMID: 22486252 Clinical Trial.

9

Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.

Fuse M, Kojima S, Enokida H, Chiyomaru T, Yoshino H, Nohata N, Kinoshita T, Sakamoto S, Naya Y, Nakagawa M, Ichikawa T, Seki N. Fuse M, et al. Among authors: sakamoto s. J Hum Genet. 2012 Nov 26;57(11):691-9. doi: 10.1038/jhg.2012.95. Epub 2012 Aug 2. J Hum Genet. 2012. PMID: 22854542

10

FOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway.

Imamura Y, Sakamoto S, Endo T, Utsumi T, Fuse M, Suyama T, Kawamura K, Imamoto T, Yano K, Uzawa K, Nihei N, Suzuki H, Mizokami A, Ueda T, Seki N, Tanzawa H, Ichikawa T. Imamura Y, et al. Among authors: sakamoto s. PLoS One. 2012;7(8):e42456. doi: 10.1371/journal.pone.0042456. Epub 2012 Aug 3. PLoS One. 2012. PMID: 22879989 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,318 results

Search Page